Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody
391101
Phase 1 mab completed
Quick answer
Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for Metastatic Adenocarcinoma of the Colon or Rectum is a Phase 1 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Metastatic Adenocarcinoma of the Colon or Rectum
- Phase
- Phase 1
- Modality
- mab
- Status
- completed